معرفی
Isabel Evi Naumann is a Research Fellow at the Biotech Research & Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen, affiliated with the Khodosevich Group under a prestigious Marie Curie Fellowship.
Her academic background includes:
- Master of Science in Biomedicine from the University of Strasbourg (2021-2023), investigating Type 2 cytokines' effects on human neuronal function
- Bachelor of Science in Molecular Medicine from Friedrich-Alexander University Erlangen-Nürnberg (2017-2021), focusing on alpha-, beta-, and gamma-synuclein characterization
Dr. Naumann's research integrates molecular neuroscience with neuroimmunology, specializing in schizophrenia mechanisms, neurodegenerative disorders, and single-cell RNA sequencing applications. Her work bridges cellular immunology and neuronal dysfunction, particularly examining microglial roles in Parkinsonian syndromes through advanced genomic techniques.
Her 2022 publication in The Journal of Neuroscience demonstrates expertise at the intersection of neuroinflammation and movement disorders, revealing complex relationships between myeloid cell modulation and disease progression in Multiple System Atrophy models.
Key recognition includes:
- Marie Curie Fellowship for her innovative neuroscience research
As a Marie Curie Fellow, she secures competitive research funding while contributing to BRIC's collaborative environment. Her current projects involve single-cell transcriptomics to dissect neuroimmune interactions in psychiatric and neurodegenerative conditions.
Dr. Naumann actively contributes to the Khodosevich Group's mission at BRIC, utilizing cutting-edge molecular techniques to investigate neurological disease mechanisms with translational potential.
